Memorial Sloan Kettering Cancer Center
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1884-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.mskcc.org
Regorafenib in Patients with Progressive, Recurrent/Metastatic Adenoid Cystic Carcinoma
- First Posted Date
- 2014-03-28
- Last Posted Date
- 2024-11-11
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 38
- Registration Number
- NCT02098538
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸Memorial Sloan Kettering Cancer Center @ Suffolk, Commack, New York, United States
🇺🇸Memorial Sloan Kettering at Mercy Medical Center, Rockville Centre, New York, United States
Quit IT: Preliminary Testing of a Web-based, 3D Coping Skills Game to Increase Quitting Self-Efficacy for Maintaining Smoking Abstinence Following Hospitalization
- Conditions
- Tobacco Use Cessation
- Interventions
- Other: web-based video game (Quit IT)Behavioral: QuestionnairesOther: Salvia sample
- First Posted Date
- 2014-03-28
- Last Posted Date
- 2020-12-30
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 50
- Registration Number
- NCT02099097
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Dual mTOR Inhibitor MLN0128 in Advanced Castration-Resistant Prostate Cancer (CRPC) Patients
- First Posted Date
- 2014-03-19
- Last Posted Date
- 2019-11-21
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 9
- Registration Number
- NCT02091531
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Development and Evaluation of Magnetic Resonance Imaging Acquisition and Analysis Methods
- Conditions
- Healthy
- Interventions
- Behavioral: MR Screening QuestionnaireDevice: Magnetic Resonance Imaging Acquisition and Analysis
- First Posted Date
- 2014-03-19
- Last Posted Date
- 2024-10-29
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 461
- Registration Number
- NCT02091518
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Kidney Cancer DNA Registry
- Conditions
- Renal Cancer
- Interventions
- Other: salvia for germline DNABehavioral: the Kidney Cancer QuestionnaireBehavioral: Family History Questionnaire (when applicable)Other: Blood drawBehavioral: Epidemiologic Questionnaire
- First Posted Date
- 2014-03-14
- Last Posted Date
- 2024-10-15
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 750
- Registration Number
- NCT02087852
- Locations
- 🇺🇸
Memorial Sloan Kettering at Basking Ridge (Consent and Follow-up), Basking Ridge, New Jersey, United States
🇺🇸Memorial Sloan Kettering Commack (Consent and Follow-up), Commack, New York, United States
🇺🇸Memorial Sloan Kettering Westchester (Consent and Follow up), Harrison, New York, United States
Study Assessing the Potential for Reduced Rates of Implant Failure Using Multi-Beam Intensity-Modulated Radiation Therapy for Locally Advanced Breast Cancer Patients With Implant Reconstructions
- Conditions
- Breast Cancer
- Interventions
- Device: Breast MRIBehavioral: Breast-Q© questionnaireRadiation: Multi-Beam IMRT
- First Posted Date
- 2014-03-13
- Last Posted Date
- 2024-04-02
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 124
- Registration Number
- NCT02086578
- Locations
- 🇺🇸
Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States
🇺🇸Memorial Sloan Kettering at Basking Ridge, Basking Ridge, New Jersey, United States
🇺🇸Memorial Sloan Kettering Cancer Center @ Suffolk, Commack, New York, United States
The Use of Dual-handset Interpreter Phones in an Inpatient Setting to Improve Communication With Limited English Proficiency Patients at MSKCC
- Conditions
- Inpatients With Limited English Proficiency
- Interventions
- Behavioral: Patient SurveyBehavioral: Provider Survey
- First Posted Date
- 2014-02-27
- Last Posted Date
- 2020-01-14
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 40
- Registration Number
- NCT02073903
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Evaluation of Molecular Forms of PSA and Human Kallikrein 2 in a Cohort of Patients With Locally Resected Prostate Cancer But Biochemical Recurrence
- Conditions
- Prostate Cancer
- Interventions
- Other: blood draw
- First Posted Date
- 2014-02-25
- Last Posted Date
- 2023-10-23
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 200
- Registration Number
- NCT02070575
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Ganetespib, Paclitaxel, Trastuzumab and Pertuzumab for Metastatic Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer
- Conditions
- Stage IIIB Breast CancerStage IIIC Breast CancerStage IV Breast CancerHER2-positive Breast CancerMale Breast CancerRecurrent Breast CancerStage IIIA Breast Cancer
- Interventions
- First Posted Date
- 2014-02-12
- Last Posted Date
- 2018-06-14
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 9
- Registration Number
- NCT02060253
- Locations
- 🇺🇸
NYU Cancer Institute, New York, New York, United States
🇺🇸Memorial Sloan-Kettering Cancer Center, New York, New York, United States
Study of Romiplostim for Chemotherapy Induced Thrombocytopenia
- Conditions
- Isolated Chemotherapy-induced Thrombocytopenia
- Interventions
- First Posted Date
- 2014-02-03
- Last Posted Date
- 2024-12-27
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 60
- Registration Number
- NCT02052882
- Locations
- 🇺🇸
Memorial Sloan Kettering at Basking Ridge, Basking Ridge, New Jersey, United States
🇺🇸Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States
🇺🇸Memorial Sloan Kettering Bergen, Montvale, New Jersey, United States